CFO admitted the current SP is too cheap and it won't be their preference to do CR to fund the expansion of the product lines at this stage
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025